263 related articles for article (PubMed ID: 26169471)
1. Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis.
Yoon YS; Keum N; Zhang X; Cho E; Giovannucci EL
Metabolism; 2015 Oct; 64(10):1324-33. PubMed ID: 26169471
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of IGF-1, IGFBP-3, and IGF-1/IGFBP-3 molar ratio and colorectal adenomas: A meta-analysis.
Yoon YS; Keum N; Zhang X; Cho E; Giovannucci EL
Cancer Epidemiol; 2015 Dec; 39(6):1026-35. PubMed ID: 26388613
[TBL] [Abstract][Full Text] [Related]
3. Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers.
Limburg PJ; Stolzenberg-Solomon RZ; Vierkant RA; Roberts K; Sellers TA; Taylor PR; Virtamo J; Cerhan JR; Albanes D
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1514-21. PubMed ID: 17162243
[TBL] [Abstract][Full Text] [Related]
4. Is there any relation between hyperinsulinemia, insulin resistance and colorectal lesions in patients with acromegaly?
Foltyn W; Kos-Kudla B; Strzelczyk J; Matyja V; Karpe J; Rudnik A; Marek B; Kajdaniuk D; Sieron A; Latos W
Neuro Endocrinol Lett; 2008 Feb; 29(1):107-12. PubMed ID: 18283256
[TBL] [Abstract][Full Text] [Related]
5. Visceral adiposity and colorectal adenomas: dose-response meta-analysis of observational studies.
Keum N; Lee DH; Kim R; Greenwood DC; Giovannucci EL
Ann Oncol; 2015 Jun; 26(6):1101-1109. PubMed ID: 25480876
[TBL] [Abstract][Full Text] [Related]
6. Association between markers of glucose metabolism and risk of colorectal cancer.
Xu J; Ye Y; Wu H; Duerksen-Hughes P; Zhang H; Li P; Huang J; Yang J; Wu Y; Xia D
BMJ Open; 2016 Jun; 6(6):e011430. PubMed ID: 27354075
[TBL] [Abstract][Full Text] [Related]
7. Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies.
Godos J; Biondi A; Galvano F; Basile F; Sciacca S; Giovannucci EL; Grosso G
World J Gastroenterol; 2017 Mar; 23(10):1909-1919. PubMed ID: 28348498
[TBL] [Abstract][Full Text] [Related]
8. Abdominal obesity and the risk of colorectal adenoma: a meta-analysis of observational studies.
Hong S; Cai Q; Chen D; Zhu W; Huang W; Li Z
Eur J Cancer Prev; 2012 Nov; 21(6):523-31. PubMed ID: 22343656
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
Yang Y; Wei RB; Xing Y; Tang L; Zheng XY; Wang ZC; Gao YW; Li MX; Chen XM
Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance, apoptosis, and colorectal adenoma risk.
Keku TO; Lund PK; Galanko J; Simmons JG; Woosley JT; Sandler RS
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2076-81. PubMed ID: 16172212
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance, central obesity, and risk of colorectal adenomas.
Ortiz AP; Thompson CL; Chak A; Berger NA; Li L
Cancer; 2012 Apr; 118(7):1774-81. PubMed ID: 22009143
[TBL] [Abstract][Full Text] [Related]
12. Iron intake, serum iron indices and risk of colorectal adenomas: a meta-analysis of observational studies.
Cao H; Wang C; Chai R; Dong Q; Tu S
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26956572
[TBL] [Abstract][Full Text] [Related]
13. Impaired Secretion of Glucagon-Like Peptide 1 in Patients with Colorectal Adenoma after an Oral Glucose Load.
Sasaki Y; Abe Y; Takeda H; Nishise S; Yaoita T; Yagi M; Sakuta K; Mizumoto N; Shoji M; Onozato Y; Kawata S; Ueno Y
Digestion; 2018; 97(4):324-332. PubMed ID: 29539609
[TBL] [Abstract][Full Text] [Related]
14. Body mass index increases risk for colorectal adenomas based on meta-analysis.
Ben Q; An W; Jiang Y; Zhan X; Du Y; Cai QC; Gao J; Li Z
Gastroenterology; 2012 Apr; 142(4):762-72. PubMed ID: 22245665
[TBL] [Abstract][Full Text] [Related]
15. Association between investigator-measured body-mass index and colorectal adenoma: a systematic review and meta-analysis of 168,201 subjects.
Wong MC; Chan CH; Cheung W; Fung DH; Liang M; Huang JL; Wang YH; Jiang JY; Yu CP; Wang HH; Wu JC; Chan FK; Sung JJ
Eur J Epidemiol; 2018 Jan; 33(1):15-26. PubMed ID: 29288474
[TBL] [Abstract][Full Text] [Related]
16. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
Li X; Zhou ZG; Qi HY; Chen XY; Huang G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
[TBL] [Abstract][Full Text] [Related]
17. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.
Esteghamati A; Khalilzadeh O; Abbasi M; Nakhjavani M; Novin L; Esteghamati AR
Clin Exp Hypertens; 2008 Jul; 30(5):297-307. PubMed ID: 18633753
[TBL] [Abstract][Full Text] [Related]
18. Association between markers of glucose metabolism and risk of colorectal adenoma.
Rampal S; Yang MH; Sung J; Son HJ; Choi YH; Lee JH; Kim YH; Chang DK; Rhee PL; Rhee JC; Guallar E; Cho J
Gastroenterology; 2014 Jul; 147(1):78-87.e3. PubMed ID: 24632359
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes mellitus and risk of colorectal adenoma: a meta-analysis of observational studies.
Yu F; Guo Y; Wang H; Feng J; Jin Z; Chen Q; Liu Y; He J
BMC Cancer; 2016 Aug; 16():642. PubMed ID: 27535548
[TBL] [Abstract][Full Text] [Related]
20. Visceral adipose tissue and the risk of colorectal adenomas: a meta-analysis of observational studies.
Hu H; Cai Y; Huang J; Zhang J; Deng Y
Eur J Cancer Prev; 2015 Nov; 24(6):462-9. PubMed ID: 25494291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
